Pages that link to Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy
Primary tabs
Cite This Article
Vancouver Style ::
Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy. Pharmacognosy Journal. 2022;14(6s):912-916.
PDF (827.57 KB)
PDF (827.57 KB)
No backlinks found.